AAOS Now, October 2026
-
Experts discuss the promises, challenges of biologics in spine care
The use of biologics for complex spine disorders is one of the fastest-growing practices in spine surgery.
-
Diagnosing pain after THA: Embrace your inner Sherlock Holmes
As total hip arthroplasty has become one of the most common surgical procedures in the United States, it has also become more effective, with many patients enjoying years of pain-free motion.
-
Opportunities exist for orthopaedic practices looking for partners
Orthopaedic practices continue to face financial challenges as Medicare reimbursement rates decrease and the cost of doing business increases.
-
Most patients achieve substantial clinical benefit after TKA, but some factors increase the risk of falling short
More than three-quarters of patients achieved substantial clinical benefit (SCB) one year after primary total knee arthroplasty (TKA), but patients with higher preoperative Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR) scores and those reporting back pain before surgery were significantly less likely to reach that benchmark, according to research presented at the AAOS 2026 Annual Meeting.
-
ARBs outperform ACE inhibitors in preventing arthrofibrosis after knee arthroplasty
A study at the AAOS 2026 Annual Meeting presented findings on the use of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) to lower the risk of arthrofibrosis following total knee arthroplasty (TKA).